Uncoupling of ATP-depletion and cell death in human dopaminergic neurons

Pöltl, Dominik; Schildknecht, Stefan; Karreman, Christiaan; Leist, Marcel

Uncoupling of ATP-depletion and cell death in human dopaminergic neurons

Dateien

Poeltl_180668.pdfGröße: 1.33 MBDownloads: 740

Datum

2012

Open Access-Veröffentlichung

Open Access Green

Sammlungen

Biologie

Publikationstyp

Zeitschriftenartikel

Publikationsstatus

Published

Erschienen in

NeuroToxicology. 2012, 33(4), pp. 769-779. ISSN 0161-813X. eISSN 1872-9711. Available under: doi: 10.1016/j.neuro.2011.12.007

Zusammenfassung

The mitochondrial inhibitor 1-methyl-4-phenylpyridinium (MPP(+)) is the toxicologically relevant metabolite of 1-methyl-4-phenyltetrahydropyridine (MPTP), which causes relatively selective degeneration of dopaminergic neurons in the substantia nigra. Dopaminergic LUHMES cells were used to investigate whether ATP-depletion can be uncoupled from cell death as a downstream event in these fully post-mitotic human neurons. Biochemical assays indicated that in the homogeneously differentiated cell cultures, MPP(+) was taken up by the dopamine transporter (DAT). MPP(+) then triggered oxidative stress and caspase activation, as well as ATP-depletion followed by cell death. Enhanced survival of the neurons in the presence of agents interfering with mitochondrial pathology, such as the fission inhibitor Mdivi-1 or a Bax channel blocker suggested a pivotal role of mitochondria in this model. However, these compounds did not prevent cellular ATP-depletion. To further investigate whether cells could be rescued despite respiratory chain inhibition by MPP(+), we have chosen a diverse set of pharmacological inhibitors well-known to interfere with MPP(+) toxicity. The antioxidant ascorbate, the iron chelator desferoxamine, the stress kinase inhibitor CEP1347, and different caspase inhibitors reduced cell death, but allowed ATP-depletion in protected cells. None of these compounds interfered with MPP(+) accumulation in the cells. These findings suggest that ATP-depletion, as the initial mitochondrial effect of MPP(+), requires further downstream processes to result in neuronal death. These processes may form self-enhancing signaling loops, that aggravate an initial energetic impairment and eventually determine cell fate.

Fachgebiet (DDC)

570 Biowissenschaften, Biologie

Schlagwörter

MPP+, dopamine, LUHMES, caspases, oxidative stress, Parkinson’s disease

Zitieren

ISO 690

PÖLTL, Dominik, Stefan SCHILDKNECHT, Christiaan KARREMAN, Marcel LEIST, 2012. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. In: NeuroToxicology. 2012, 33(4), pp. 769-779. ISSN 0161-813X. eISSN 1872-9711. Available under: doi: 10.1016/j.neuro.2011.12.007

BibTex

@article{Poltl2012-08Uncou-18066,
  year={2012},
  doi={10.1016/j.neuro.2011.12.007},
  title={Uncoupling of ATP-depletion and cell death in human dopaminergic neurons},
  number={4},
  volume={33},
  issn={0161-813X},
  journal={NeuroToxicology},
  pages={769--779},
  author={Pöltl, Dominik and Schildknecht, Stefan and Karreman, Christiaan and Leist, Marcel}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/18066">
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-08-14T11:33:37Z</dc:date>
    <dc:creator>Schildknecht, Stefan</dc:creator>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/18066"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Schildknecht, Stefan</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-08-14T11:33:37Z</dcterms:available>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:abstract xml:lang="eng">The mitochondrial inhibitor 1-methyl-4-phenylpyridinium (MPP(+)) is the toxicologically relevant metabolite of 1-methyl-4-phenyltetrahydropyridine (MPTP), which causes relatively selective degeneration of dopaminergic neurons in the substantia nigra. Dopaminergic LUHMES cells were used to investigate whether ATP-depletion can be uncoupled from cell death as a downstream event in these fully post-mitotic human neurons. Biochemical assays indicated that in the homogeneously differentiated cell cultures, MPP(+) was taken up by the dopamine transporter (DAT). MPP(+) then triggered oxidative stress and caspase activation, as well as ATP-depletion followed by cell death. Enhanced survival of the neurons in the presence of agents interfering with mitochondrial pathology, such as the fission inhibitor Mdivi-1 or a Bax channel blocker suggested a pivotal role of mitochondria in this model. However, these compounds did not prevent cellular ATP-depletion. To further investigate whether cells could be rescued despite respiratory chain inhibition by MPP(+), we have chosen a diverse set of pharmacological inhibitors well-known to interfere with MPP(+) toxicity. The antioxidant ascorbate, the iron chelator desferoxamine, the stress kinase inhibitor CEP1347, and different caspase inhibitors reduced cell death, but allowed ATP-depletion in protected cells. None of these compounds interfered with MPP(+) accumulation in the cells. These findings suggest that ATP-depletion, as the initial mitochondrial effect of MPP(+), requires further downstream processes to result in neuronal death. These processes may form self-enhancing signaling loops, that aggravate an initial energetic impairment and eventually determine cell fate.</dcterms:abstract>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/18066/2/Poeltl_180668.pdf"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:issued>2012-08</dcterms:issued>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:creator>Pöltl, Dominik</dc:creator>
    <dcterms:bibliographicCitation>Publ. in: Neurotoxicology ; 33 (2012), 4. - S. 769-779</dcterms:bibliographicCitation>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/18066/2/Poeltl_180668.pdf"/>
    <dc:contributor>Karreman, Christiaan</dc:contributor>
    <dc:language>eng</dc:language>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Pöltl, Dominik</dc:contributor>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dc:creator>Karreman, Christiaan</dc:creator>
    <dcterms:title>Uncoupling of ATP-depletion and cell death in human dopaminergic neurons</dcterms:title>
  </rdf:Description>
</rdf:RDF>

Universitätsbibliographie

Ja